Financhill
Back

Relay Therapeutics Stock Predictions

Relay Therapeutics Stock Forecast

  • Is Relay Therapeutics Stock Undervalued?
    The current Relay Therapeutics [RLAY] share price is $4.00. The Score for RLAY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Relay Therapeutics Stock Go Up Next Year?

Data Unavailable

Relay Therapeutics Stock Rating

Data Unavailable

Relay Therapeutics Stock Price History

Is RLAY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
relaytx.com

52-Week Data

52-Week High:
11.16
52-Week Low:
3.50

Prediction Charts

Market Cap:
669.5M
Price in USD:
4.00
Volume:
1.1M
Beta:
1.62

Technical Analysis

SMA50:
4.44
SMA100:
5.26
SMA200:
6.24
52-Wk Change:
-59.56%

Stock Predictions

  • Is Relay Therapeutics stock public?
    Yes, Relay Therapeutics is a publicly traded company.
  • What is the Relay Therapeutics stock quote today?
    The Relay Therapeutics stock price is 4.00 USD today.
  • How to buy Relay Therapeutics stock online?
    You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-28 4.70 4.62 4.78 4.25
Jan-29 4.55 4.48 4.68 4.41
Jan-30 4.42 4.54 4.65 4.42
Jan-31 4.58 4.47 4.68 4.44
Feb-3 4.28 4.47 4.61 4.25
Feb-4 4.47 4.63 4.66 4.38
Feb-5 4.63 4.79 4.86 4.63
Feb-6 4.81 4.51 4.85 4.51
Feb-7 4.53 4.22 4.59 4.17
Feb-10 4.21 4.01 4.21 4.01
Feb-11 3.85 3.74 4.02 3.73
Feb-12 3.63 3.76 3.76 3.61
Feb-13 3.70 3.96 3.96 3.69
Feb-14 3.95 4.00 4.16 3.88

Relay Therapeutics Earnings

Data Unavailable

Relay Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.04 per share.

* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.